Neurotech CEO Rich Small on ENCELTO™ and Redefining Retinal Cell-Based Gene Therapy | Eyecelerator 2025
At Eyecelerator 2025, Neurotech CEO Rich Small shares the story behind ENCELTO™, a first-in-class encapsulated cell-based gene therapy for the…
ARVO 2025 Day 4: Retina and Glaucoma Genetics, Award Lectures and AI Fatigue (?!)
Game changing genetics takes center stage, and Prof. Pearse Keane asks an unthinkable question about AI in ophthalmology on ARVO…